BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9550397)

  • 1. Activation-related differences in HLA class I-bound peptides: presentation of an IL-1 receptor antagonist-derived peptide by activated, but not resting, CD4+ T lymphocytes.
    Frumento G; Corradi A; Ferrara GB; Rubartelli A
    J Immunol; 1997 Dec; 159(12):5993-9. PubMed ID: 9550397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
    Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
    J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T lymphocyte proliferative response to resting porcine endothelial cells results from an HLA-restricted, IL-10-sensitive, indirect presentation pathway but also depends on endothelial-specific costimulatory factors.
    Vallée I; Guillaumin JM; Thibault G; Gruel Y; Lebranchu Y; Bardos P; Watier H
    J Immunol; 1998 Aug; 161(4):1652-8. PubMed ID: 9712027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
    Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion.
    Shi M; Hao S; Chan T; Xiang J
    J Leukoc Biol; 2006 Dec; 80(6):1354-63. PubMed ID: 16980510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity.
    Molinero LL; Domaica CI; Fuertes MB; Girart MV; Rossi LE; Zwirner NW
    Hum Immunol; 2006 Mar; 67(3):170-82. PubMed ID: 16698439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes.
    Dangles V; Halberstam I; Scardino A; Choppin J; Wertheimer M; Richon S; Quelvennec E; Moirand R; Guillet JG; Kosmatopoulos K; Bellet D; Zeliszewski D
    Cancer Immunol Immunother; 2002 Feb; 50(12):673-81. PubMed ID: 11862419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
    Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
    J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.
    Wu Y; Farrell J; Pirmohamed M; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2007 Apr; 119(4):973-81. PubMed ID: 17320939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.